Mediwound Ltd (MDWD)

Nov 14, 2024

MediWound to Discuss New Share Incentive Plan - TipRanks

Nov 14, 2024

Nov 12, 2024

MediWound to Report Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

MediWound Q3 2024 Earnings Call Scheduled for November 26: What to Expect | MDWD Stock News - StockTitan

Nov 12, 2024

Nov 09, 2024

99,994 Shares in MediWound Ltd. (NASDAQ:MDWD) Bought by ARK Investment Management LLC - MarketBeat

Nov 09, 2024

Nov 06, 2024

MediWound Ltd. (NASDAQ:MDWD) is Rosalind Advisors Inc.'s 5th Largest Position - MarketBeat

Nov 06, 2024

Nov 05, 2024

MediWound (STU:M8W) Financial Strength : 6 (As of Jun. 2024) - GuruFocus.com

Nov 05, 2024

Nov 02, 2024

How the (MDWD) price action is used to our Advantage - Stock Traders Daily

Nov 02, 2024

Oct 29, 2024

MediWound Is A Healthy Investment (NASDAQ:MDWD) - Seeking Alpha

Oct 29, 2024

Oct 27, 2024

MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year - Yahoo Finance UK

Oct 27, 2024

Oct 23, 2024

Rosalind Advisors, Inc. Increases Stake in MediWound Ltd - Yahoo Finance

Oct 23, 2024

Oct 23, 2024

(MDWD) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 23, 2024

Oct 13, 2024

MediWound (NASDAQ:MDWD) Rating Reiterated by HC Wainwright - Defense World

Oct 13, 2024

Oct 12, 2024

Trading (MDWD) With Integrated Risk Controls - Stock Traders Daily

Oct 12, 2024

Oct 12, 2024

MediWound shares maintain buy rating on new study plans - Investing.com India

Oct 12, 2024

Oct 12, 2024

MediWound shares maintain buy rating on new study plans By Investing.com - Investing.com South Africa

Oct 12, 2024

Oct 11, 2024

MediWound (NASDAQ:MDWD) Earns Buy Rating from HC Wainwright - MarketBeat

Oct 11, 2024

Oct 11, 2024

MediWound advances EscharEx in Phase II VLU study By Investing.com - Investing.com Australia

Oct 11, 2024

Oct 10, 2024

MediWound advances EscharEx in Phase II VLU study - Investing.com India

Oct 10, 2024

Oct 10, 2024

MediWound Announces Phase II Head-to-Head Study Evaluating - GlobeNewswire

Oct 10, 2024

Oct 08, 2024

MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times

Oct 08, 2024

Oct 01, 2024

(MDWD) On The My Stocks Page - Stock Traders Daily

Oct 01, 2024

Sep 30, 2024

Rhumbline Advisers Purchases Shares of 8,440 MediWound Ltd. (NASDAQ:MDWD) - Defense World

Sep 30, 2024

Sep 20, 2024

Objective long/short (MDWD) Report - Stock Traders Daily

Sep 20, 2024

Sep 18, 2024

TD Cowen maintains Buy rating on MediWound shares with no price target change - Investing.com

Sep 18, 2024

Sep 11, 2024

MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200-Day Moving Average of $16.99 - MarketBeat

Sep 11, 2024

Sep 05, 2024

(MDWD) Long Term Investment Analysis - Stock Traders Daily

Sep 05, 2024

Sep 03, 2024

MediWound (NASDAQ:MDWD) Shares Cross Above 50 Day Moving Average of $18.20 - MarketBeat

Sep 03, 2024

Sep 03, 2024

MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 03, 2024

Aug 28, 2024

Critical Comparison: MediWound (NASDAQ:MDWD) versus Jinhua Marine Biological (OTCMKTS:JNMB) - Defense World

Aug 28, 2024

Aug 21, 2024

MediWound Ltd.'s (NASDAQ:MDWD) top owners are retail investors with 38% stake, while 28% is held by institutions - Yahoo Finance

Aug 21, 2024

Aug 20, 2024

MDWDMediWound Ltd. Latest Stock News & Market Updates - StockTitan

Aug 20, 2024

Aug 19, 2024

MediWound Ltd. Forecasted to Post Q3 2024 Earnings of ($0.49) Per Share (NASDAQ:MDWD) - MarketBeat

Aug 19, 2024

Aug 19, 2024

Brokers Set Expectations for MediWound Ltd.’s Q3 2024 Earnings (NASDAQ:MDWD) - Defense World

Aug 19, 2024

Aug 18, 2024

MediWound (FRA:M8W) Median PS Value : €30.03 (As of Aug. 24, 2024) - GuruFocus.com

Aug 18, 2024

Aug 18, 2024

MDWD (MediWound) Free Cash Flow : $-22.27 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 18, 2024

Aug 17, 2024

HC Wainwright Reiterates Buy Rating for MediWound (NASDAQ:MDWD) - Defense World

Aug 17, 2024

Aug 17, 2024

MediWound Ltd. (NASDAQ:MDWD) Forecasted to Earn FY2027 Earnings of $1.28 Per Share - Defense World

Aug 17, 2024

Aug 16, 2024

Equities Analysts Offer Predictions for MediWound Ltd.'s FY2027 Earnings (NASDAQ:MDWD) - MarketBeat

Aug 16, 2024

Aug 16, 2024

MediWound and Vericel win FDA paediatric label expansion for NexoBrid - Medical Device Network

Aug 16, 2024

Aug 16, 2024

MediWound shares hold Buy rating with steady target on expansion By Investing.com - Investing.com Australia

Aug 16, 2024

Aug 16, 2024

MediWound Second Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St

Aug 16, 2024

Aug 15, 2024

MediWound Announces U.S. Food and Drug Administration - GlobeNewswire

Aug 15, 2024

Aug 15, 2024

Vericel, MediWound climb on FDA's expanded approval for skin treatment - XM

Aug 15, 2024

Aug 15, 2024

MediWound’s NexoBrid Gains FDA Pediatric Approval - TipRanks

Aug 15, 2024

Aug 15, 2024

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns - StockTitan

Aug 15, 2024

Aug 15, 2024

MediWound shares hold Buy rating with steady target on expansion - Investing.com

Aug 15, 2024